Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass Balance and Bioavailability of Daprodustat in Healthy Males
NCT03239522Phase 1Completed
- Sponsor
- GSK
- Start
- Oct 2017
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of daprodustat in anemia, sponsored by GSK. Primary endpoints: Area Under the Concentration-time Curve From Time Zero Extrapolated to Infinite Time of Total Drug-related Material in Plasma at 144 hours, Area Under the Concentration-time Curve From Time Zero Extrapolated to Infinite Time of Total Drug-related Material in Blood at 144 hours and 4 more. Started Oct 2017; status: completed.
02
Drugs
daprodustat
03
Conditions
anemia
Beyond the preview
Go deeper on NCT03239522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03239522.